WW launches WeightWatchers RxFlexFund

WW (WW) International announced the launch of WeightWatchers RxFlexFund, a solution that combines direct pricing from pharmaceutical manufacturers with flexible employer subsidy coverage for GLP-1s, integrated with WeightWatchers’ full-spectrum behavioral and clinical support. With WeightWatchers RxFlexFund, employers cover the cost of WeightWatchers Clinic and contribute a set percentage of medication costs, ranging from 25% to 75%, to help offset the impact of GLP-1 medication costs for their employees. Through this solution, employers also gain access to direct manufacturer pricing, providing transparent, competitive costs.